Grail Inc (GRAL) Stock Price, Quote & News

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 833 694 2553

Website: grail.com

Address:

1525 O’Brien Drive, Menlo Park, United States

RebeccaLeonhart889 Feb. 4 at 3:09 PM

$TOYO $GRAL International exposure

0 · Reply

notreload_ai Feb. 4 at 2:26 PM

$HIMS partners with $GRAL to offer discounted Galleri cancer detection tests through its Labs subscription service, expanding beyond weight-loss treatments. https://notreload.xyz/hims-adds-cancer-detection-test-to-labs-product/

0 · Reply

RealWASP Feb. 4 at 2:07 PM

$GRAL Let's see if we get institutional volume at market open!

0 · Reply

603stockgoat Feb. 4 at 2:04 PM

$HIMS and $GRAL partner up , fuck cancer

0 · Reply

QuantumYolo Feb. 4 at 9:04 AM

$GRAL Brazilian agribusiness exposure, volatile earnings

1 · Reply

Benhem612 Feb. 3 at 9:40 PM

$GRAL the bill was passed as part of the finding bill. https://www.fightcancer.org/policy-resources/nancy-gardner-sewell-medicare-multi-cancer-early-detection-screening-coverage-act

0 · Reply

CM22 Feb. 3 at 4:22 PM

$GRAL Get ready for blast off https://grail.com/press-releases/grail-submits-fda-premarket-approval-application-for-the-galleri-multi-cancer-early-detection-test/?fbclid=IwY2xjawPu_69leHRuA2FlbQIxMABicmlkETFGTW1HMzFIQTlkbTNEc0Vzc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHpfQA0pyl34KGobD5ygU0vqw5sN4cjeMINDSE3xSBVF6CDUK1uH-JQ0DuR0B_aem_q3C0k1--yoOJkAty2U_2jw

0 · Reply

Judykay Feb. 3 at 1:55 AM

$GRAL I know about this test. New here, I know people who have had it. I am in!

0 · Reply

Judykay Feb. 3 at 1:47 AM

$GRAL When is earnings, thank you in advance. I did look on their site. I found one date March 8

0 · Reply

JFDI Feb. 2 at 10:02 PM

$GRAL set 2 go again?

0 · Reply

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

Jan 26, 2026, 8:00 AM EST - 9 days ago

A Study on Aging Unlocks Holy Grail of Sports Performance

Jan 20, 2026, 8:34 AM EST - 15 days ago

GRAIL Inc. - Illumina's Divested Holy Grail

ILMN

Jan 12, 2026, 1:16 PM EST - 23 days ago

GRAIL, Inc. (GRAL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 15, 2025, 4:01 PM EST - 7 weeks ago

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 4:01 PM EST - 2 months ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Nov 24, 2025, 9:11 AM EST - 2 months ago

Deutsche Bank may have just set a holy-grail goal for the S&P 500

DB IVV SPXL SPY SSO UPRO VOO

Nov 18, 2025, 4:02 PM EST - 2 months ago

GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 12:58 PM EST - 2 months ago

Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold

Nov 12, 2025, 6:21 PM EST - 2 months ago

GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 4:02 PM EST - 2 months ago

GRAIL Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 4:02 PM EST - 3 months ago

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Nov 4, 2025, 3:15 PM EST - 3 months ago

Top Biotech Stocks Riding The Rally

CTMX GRFS INCY

Oct 29, 2025, 4:02 PM EDT - 3 months ago

GRAIL to Announce Third Quarter 2025 Financial Results

Oct 27, 2025, 7:00 AM EDT - 3 months ago

GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Oct 22, 2025, 8:05 PM EDT - 3 months ago

Odds of these speculative stocks making you money seems very slim, says Jim Cramer

ASTS TGEN TMQ AUR RGTI

Oct 20, 2025, 5:05 PM EDT - 3 months ago

GRAIL, Inc. (GRAL) Discusses PATHFINDER 2 Study Results and Clinical Program in Multi-Cancer Early Detection Transcript

Oct 20, 2025, 6:30 AM EDT - 3 months ago

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

Oct 20, 2025, 6:00 AM EDT - 3 months ago

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

Oct 17, 2025, 6:08 PM EDT - 3 months ago

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

Oct 17, 2025, 9:55 AM EDT - 3 months ago

What's Happening With GRAIL Stock?

Oct 16, 2025, 8:22 AM EDT - 3 months ago

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Sep 30, 2025, 12:17 PM EDT - 4 months ago

Grail: A Speculative Buy

Sep 23, 2025, 9:01 AM EDT - 4 months ago

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

Sep 19, 2025, 8:47 AM EDT - 4 months ago

Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry

Sep 10, 2025, 4:02 PM EDT - 5 months ago

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 9, 2025, 5:31 PM EDT - 5 months ago

GRAIL, Inc. (GRAL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 28, 2025, 6:20 AM EDT - 5 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR ILMN IONS MRNA RGEN

Aug 26, 2025, 4:02 PM EDT - 5 months ago

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 12, 2025, 7:13 PM EDT - 6 months ago

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:02 PM EDT - 6 months ago

GRAIL Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Announce Second Quarter 2025 Financial Results

Jun 23, 2025, 5:30 AM EDT - 8 months ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 18, 2025, 12:43 PM EDT - 8 months ago

Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 9:01 AM EDT - 8 months ago

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

May 21, 2025, 4:05 PM EDT - 9 months ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025

May 14, 2025, 8:13 AM EDT - 9 months ago

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

ALC

May 13, 2025, 7:16 PM EDT - 9 months ago

GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 9 months ago

GRAIL Reports First Quarter 2025 Financial Results

May 12, 2025, 4:01 PM EDT - 9 months ago

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

Apr 29, 2025, 4:01 PM EDT - 10 months ago

GRAIL to Announce First Quarter 2025 Financial Results

Apr 22, 2025, 4:01 PM EDT - 10 months ago

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

Apr 21, 2025, 4:47 PM EDT - 10 months ago

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Apr 12, 2025, 9:32 AM EDT - 10 months ago

GRAIL's Galleri Progresses While Back In Accumulation Levels

Apr 8, 2025, 9:49 AM EDT - 10 months ago

How Does GRAIL Benefit From The Proposed MCED Legislation?

Feb 25, 2025, 9:00 AM EST - 1 year ago

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

Feb 21, 2025, 9:00 AM EST - 1 year ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 10:09 PM EST - 1 year ago

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:02 PM EST - 1 year ago

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

RebeccaLeonhart889 Feb. 4 at 3:09 PM

$TOYO $GRAL International exposure

0 · Reply

notreload_ai Feb. 4 at 2:26 PM

0 · Reply

RealWASP Feb. 4 at 2:07 PM

$GRAL Let's see if we get institutional volume at market open!

0 · Reply

603stockgoat Feb. 4 at 2:04 PM

$HIMS and $GRAL partner up , fuck cancer

0 · Reply

QuantumYolo Feb. 4 at 9:04 AM

$GRAL Brazilian agribusiness exposure, volatile earnings

1 · Reply

Benhem612 Feb. 3 at 9:40 PM

$GRAL the bill was passed as part of the finding bill. https://www.fightcancer.org/policy-resources/nancy-gardner-sewell-medicare-multi-cancer-early-detection-screening-coverage-act

0 · Reply

CM22 Feb. 3 at 4:22 PM

0 · Reply

Judykay Feb. 3 at 1:55 AM

$GRAL I know about this test. New here, I know people who have had it. I am in!

0 · Reply

Judykay Feb. 3 at 1:47 AM

$GRAL When is earnings, thank you in advance. I did look on their site. I found one date March 8

0 · Reply

JFDI Feb. 2 at 10:02 PM

$GRAL set 2 go again?

0 · Reply

Benhem612 Feb. 2 at 5:52 PM

$GRAL once the partial government shutdown ends this goes official. The test used by the Dallas cowboys referenced in the press release was Grails. https://arrington.house.gov/news/documentsingle.aspx?DocumentID=4293

0 · Reply

Bazzzigar Feb. 2 at 2:11 AM

$GRAL HIMS

0 · Reply

ZacksResearch Jan. 30 at 7:08 PM

$GRAL hits a key milestone with FDA submission! 🚀 GRAIL submitted the final module of its PMA application for the Galleri MCED test, leveraging strong U.S. and U.K. study data. With its Breakthrough Device designation, FDA approval could be a game-changer, sparking broader adoption and sustained revenue growth in oncology diagnostics, although shares remained almost flat recently. Discover the full story here 👉 https://www.zacks.com/stock/news/2826441/grail-submits-fda-pma-for-galleri-multi-cancer-early-detection-test?cid=sm-stocktwits-2-2826441-body-31343&ADID=SYND_STOCKTWITS_TWEET_2_2826441_BODY_31343

0 · Reply

Benhem612 Jan. 30 at 5:14 PM

$GRAL https://www.prnewswire.com/news-releases/grail-submits-fda-premarket-approval-application-for-the-galleri-multi-cancer-early-detection-test-302674611.html

0 · Reply

Benhem612 Jan. 30 at 3:07 PM

$GRAL today is all about if Congress can get the non-dhs bills over the finish line. MCED bill is part of it and would be great for Grail.

0 · Reply

BillionerOfKing Jan. 30 at 3:14 AM

$GRAL Current Stock Price: $100.98 Contracts to trade: $100 GRAL Feb 20 2026 Call Entry: $9.10 Exit: $15.47 ROI: 70% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

WAJeff Jan. 29 at 4:10 PM

$GRAL add 98.01

1 · Reply

Thelonius_Stonk Jan. 28 at 11:50 AM

$GRAL angry tight

1 · Reply

Benhem612 Jan. 27 at 12:17 PM

$GRAL https://www.nationalreview.com/2026/01/congress-can-change-the-cancer-story-with-a-vote/

0 · Reply

Thelonius_Stonk Jan. 26 at 3:25 PM

$GRAL show da shake n bake

0 · Reply

DarvasBoxGuru Jan. 24 at 3:32 PM

$GRAL had an alert for a Darvas Box breakout this week. It didn't stick but it is still a top watch-list name IMO

0 · Reply

CapitalGains007 Jan. 24 at 4:28 AM

$GRAL Galleri missed my cancer, two years in a row. $2K for 2 missed diagnoses. Thank god for other screening and blood work

2 · Reply

Market Cap	3.81B
Revenue (ttm)	125.60M
Net Income (ttm)	-2.03B
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,613.86%
Debt to Equity Ratio	0.00

Volume	531,975
Avg Vol	906,184
Day's Range	N/A - N/A
Shares Out	38.98M
Stochastic %K	38%
Beta	4.52
Analysts	Sell
Price Target	$115.00